Meiyan Sun
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Molecular Biology top 10%
- RNA Interference and Gene Delivery
- Extracellular vesicles in disease
- Advanced biosensing and bioanalysis techniques
- Ion channel regulation and function
Papers in
-
- Sphingolipid Metabolism and Signaling 3
- Renal and related cancers 3
- Ion channel regulation and function 3
-
- HIV/AIDS Research and Interventions 6
- HIV/AIDS drug development and treatment 3
- Co-authors
- Bin Guo (6 shared papers)Peixuan Guo (2 shared papers)Tonghui Ma (8 shared papers)Tae Jin Lee (1 shared paper)Hui Li (1 shared paper)Carlo M. Croce (1 shared paper)B. Mark Evers (1 shared paper)Zhefeng Li (1 shared paper)
- Journals
- Frontiers in Bioengineering and Biotechnology (4 papers)PLoS ONE (3 papers)BioScience Trends (2 papers)Tissue and Cell (2 papers)Current Pharmaceutical Design (2 papers)
- Partner nations
- ChinaUnited StatesPakistan
In The Last Decade
Meiyan Sun
50 papers receiving 1.9k citations
Meiyan Sun's Hit Papers
Peers
Comparison fields: 5 of 131
- Cancer Research 406
- Molecular Biology 1.1k
- Virology 54
- Toxicology 35
- Sensory Systems 46
Countries citing papers authored by Meiyan Sun
This map shows the geographic impact of Meiyan Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meiyan Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meiyan Sun more than expected).
Fields of papers citing papers by Meiyan Sun
This network shows the impact of papers produced by Meiyan Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meiyan Sun. The network helps show where Meiyan Sun may publish in the future.
Co-authors
The 25 scholars most cited alongside Meiyan Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Nanoparticle orientation to control RNA loading and ligand display on extracellular vesicles for cancer regression Hit paper breakdown → | 2017 | 417 |
| 2 | 2018 | 149 | |
| 3 | 2012 | 107 | |
| 4 | 2014 | 103 | |
| 5 | 2016 | 93 | |
| 6 | 2014 | 69 | |
| 7 | 2020 | 67 | |
| 8 | 2021 | 56 | |
| 9 | 2019 | 54 | |
| 10 | 2016 | 53 | |
| 11 | 2006 | 44 | |
| 12 | 2022 | 44 | |
| 13 | 2020 | 42 | |
| 14 | 2016 | 37 | |
| 15 | 2018 | 37 | |
| 16 | 2014 | 35 | |
| 17 | 2015 | 34 | |
| 18 | 2016 | 31 | |
| 19 | 2019 | 31 | |
| 20 | 2013 | 28 |
About Meiyan Sun
Meiyan Sun is a scholar working on Molecular Biology, Infectious Diseases, Oncology, Public Health, Environmental and Occupational Health and Pathology and Forensic Medicine, having authored 50 papers that have together received 1.9k indexed citations. Recurring topics across this work include HIV/AIDS Research and Interventions (6 papers), HIV Research and Treatment (4 papers), Sphingolipid Metabolism and Signaling (3 papers), Maternal Mental Health During Pregnancy and Postpartum (3 papers), Renal and related cancers (3 papers), Ion channel regulation and function (3 papers), Peripheral Neuropathies and Disorders (3 papers) and HIV/AIDS drug development and treatment (3 papers). The work is most often cited by research in Cancer Research (406 citations), Molecular Biology (1.1k citations), Virology (54 citations), Toxicology (35 citations) and Sensory Systems (46 citations). Meiyan Sun has collaborated with scholars based in China, United States and Pakistan. Frequent co-authors include Bin Guo, Peixuan Guo, Tonghui Ma, Tae Jin Lee, Hui Li, Carlo M. Croce, B. Mark Evers, Zhefeng Li, Fengmei Pi and Piotr Rychahou. Their work appears in journals such as Frontiers in Bioengineering and Biotechnology, PLoS ONE, BioScience Trends, Tissue and Cell and Current Pharmaceutical Design.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.